diethyl 4-(4-morpholinyl)-pyridine-2,6-dicarboxylate | 1207095-53-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: diethyl 4-(4-morpholinyl)-pyridine-2,6-dicarboxylate
• 英文别名: Diethyl-4-(4-morpholinyl)-pyridin-2,6-dicarboxylat；Diethyl 4-morpholin-4-ylpyridine-2,6-dicarboxylate
• CAS: 1207095-53-1
• 化学式: C₁₅H₂₀N₂O₅
• 分子量: 308.334
• InChiKey: DXDPROZHTSLRJB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  22
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  78
• 氢给体数：
  0
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  diethyl 4-(4-morpholinyl)-pyridine-2,6-dicarboxylate 在 sodium tetrahydroborate 、 calcium chloride 作用下， 以 乙醇 为溶剂， 以69%的产率得到ethyl 6-hydroxymethyl-4-morpholino-2-pyridinecarboxylate
  参考文献：
  名称：

  Optimization of a series of 2,4-diaminopyridines as neuropeptide Y Y1 receptor antagonists with reduced hERG activity

  摘要：

  The synthesis and evaluation of a series of 2,4-diaminopyridine-based neuropeptide Y Y1 ( NPY Y1) receptor antagonists are described. Compound 1 was previously reported by our laboratory to be a potent and selective Y1 antagonist; however, 1 was also found to have potent hERG inhibitory activity. The main focus of this communication is structure-activity relationship development aimed at eliminating the hERG activity of 1. This resulted in the identification of compound 3d as a potent and selective NPY Y1 antagonist with reduced hERG liability. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.05.069
• 作为产物：
  描述：

  乙醇 、 4-Morpholino-pyridine-2,6-dicarboxylic acid 在 硫酸 作用下， 以95%的产率得到diethyl 4-(4-morpholinyl)-pyridine-2,6-dicarboxylate
  参考文献：
  名称：

  Optimization of a series of 2,4-diaminopyridines as neuropeptide Y Y1 receptor antagonists with reduced hERG activity

  摘要：

  The synthesis and evaluation of a series of 2,4-diaminopyridine-based neuropeptide Y Y1 ( NPY Y1) receptor antagonists are described. Compound 1 was previously reported by our laboratory to be a potent and selective Y1 antagonist; however, 1 was also found to have potent hERG inhibitory activity. The main focus of this communication is structure-activity relationship development aimed at eliminating the hERG activity of 1. This resulted in the identification of compound 3d as a potent and selective NPY Y1 antagonist with reduced hERG liability. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.05.069

文献信息

• [EN] 4-SUBSTITUTED PYRIDINE-2,6-DICARBOXYLIC ACID DERIVATIVES AND METHOD OF PREPARING SAME<br/>[FR] DÉRIVÉS D'ACIDE PYRIDINE-2,6-DICARBOXYLIQUE 4-SUBSTITUÉS ET LEUR PROCÉDÉ DE PRÉPARATION
  申请人：OKINAWA INST OF SCIENCE AND TECHNOLOGY SCHOOL CORP

  公开号：WO2016038890A1

  公开（公告）日：2016-03-17

  The present invention relates to novel 4-substituted pyridine-2,6-dicarboxylic acid derivatives, compounds of formula I, wherein R1 and R2are defined herein. The compounds of formula I are useful for making pharmaceutical compositions to treat proliferative diseases. The present invention also relates to concise methods for preparing compounds of formula I that may be performed under mild reaction conditions.

  本发明涉及新颖的4-取代吡啶-2,6-二羧酸衍生物，化合物的化学式为I，其中R1和R2如本文所定义。化合物的化学式I可用于制备用于治疗增殖性疾病的药物组合物。本发明还涉及用于制备化合物的简洁方法，该方法可在温和的反应条件下进行。
• 4-SUBSTITUTED PYRIDINE-2,6-DICARBOXYLIC ACID DERIVATIVES AND METHOD OF PREPARING SAME
  申请人：Okinawa Institute of Science and Technology School Corporation

  公开号：EP3191451B1

  公开（公告）日：2019-06-05